Australasian recurrent pregnancy loss clinical management guideline 2024, part II
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Part II of the Australasian guideline for the investigation and management of recurrent pregnancy loss (RPL) provides evidence-based guidance on the management of RPL provided. The implications of inherited and acquired thrombophilia with respect to RPL and suggestions for clinical management are provided. Autoimmune factors, including human leukocyte antigen, cytokines, antinuclear antibodies and coeliac antibodies, and guidance for management are discussed. Infective, inflammatory and endometrial causes of RPL are discussed in detail. Environmental and lifestyle factors, male factor and unexplained causes are outlined. Levels of evidence and grades of consensus are provided for all evidence-based statements.
Description
© 2024 The Author(s). Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Citation
the Australasian CREI (Certificate of Reproductive Endocrinology and Infertility) Consensus Expert Panel on Trial Evidence (ACCEPT) group 2024, 'Australasian recurrent pregnancy loss clinical management guideline 2024, part II', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 64, no. 5, pp. 445-458. https://doi.org/10.1111/ajo.13820
Collections
Source
Book Title
Australian and New Zealand Journal of Obstetrics and Gynaecology